BRPI0410546A - dispositivo de ruptura de liberação controlada com uma passagem pré-formada - Google Patents

dispositivo de ruptura de liberação controlada com uma passagem pré-formada

Info

Publication number
BRPI0410546A
BRPI0410546A BRPI0410546-0A BRPI0410546A BRPI0410546A BR PI0410546 A BRPI0410546 A BR PI0410546A BR PI0410546 A BRPI0410546 A BR PI0410546A BR PI0410546 A BRPI0410546 A BR PI0410546A
Authority
BR
Brazil
Prior art keywords
release
active agent
controlled release
pass
break device
Prior art date
Application number
BRPI0410546-0A
Other languages
English (en)
Inventor
Joaquina Faour
Juan A Vergez
Original Assignee
Osmotica Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33476979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0410546(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Osmotica Corp filed Critical Osmotica Corp
Publication of BRPI0410546A publication Critical patent/BRPI0410546A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • External Artificial Organs (AREA)

Abstract

"DISPOSITIVO DE RUPTURA DE LIBERAçãO CONTROLADA COM UMA PASSAGEM PRé-FORMADA". A presente invenção refere-se a um dispositivo osmótico simples e aperfeiçoado capaz de prover a liberação controlada de um agente ativo contido no núcleo ao ambiente de uso, primeiro, através da passagem pré-formada e, depois, através da segunda passagem formando no lugar. Uma ou ambas as passagens incrementam opcionalmente seu tamanho durante o uso do dispositivo osmótico. A passagem pré-formada e/ou a segunda passagem incrementam a velocidade de liberação do agente ativo, permitem a liberação de partículas maiores que contém o agente ativo, e/ou permitem a liberação de agentes ativos que são substancialmente insolúveis no ambiente de uso. Em virtude da formação no lugar da segunda abertura, o dispositivo é capaz de liberar uma porcentagem superior de agente ativo do que liberaria na ausência da segunda abertura.
BRPI0410546-0A 2003-05-22 2004-05-21 dispositivo de ruptura de liberação controlada com uma passagem pré-formada BRPI0410546A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47281903P 2003-05-22 2003-05-22
PCT/CR2004/000005 WO2004103349A2 (es) 2003-05-22 2004-05-21 Dispositivo de ruptura de liberación controlada con un pasaje preformado

Publications (1)

Publication Number Publication Date
BRPI0410546A true BRPI0410546A (pt) 2006-06-20

Family

ID=33476979

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410546-0A BRPI0410546A (pt) 2003-05-22 2004-05-21 dispositivo de ruptura de liberação controlada com uma passagem pré-formada

Country Status (8)

Country Link
EP (1) EP1629835A2 (pt)
KR (2) KR20060015286A (pt)
AR (1) AR047204A1 (pt)
BR (1) BRPI0410546A (pt)
CA (1) CA2526464C (pt)
CL (1) CL2004001192A1 (pt)
UY (1) UY28326A1 (pt)
WO (1) WO2004103349A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE512659T1 (de) 2003-04-24 2011-07-15 Jagotec Ag Tablette mit verzögerter wirkstofffreigabe und bestimmter formgeometrie
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
DK2049123T4 (en) 2006-08-03 2016-11-28 Horizon Pharma Ag LATE discharge-glucocorticoid treatment of rheumatoid ILLNESS
EP2099431B1 (en) * 2006-11-28 2013-06-05 Laboratorios Liconsa, S.A. Stabilized solid pharmaceutical composition of candesartan cilexetil
WO2008070118A1 (en) * 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
RU2470635C2 (ru) * 2007-05-11 2012-12-27 Сантен Фармасьютикал Ко., Лтд. Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
WO2010134097A2 (en) * 2009-05-22 2010-11-25 Alkem Laboratories Ltd. Stable pharmaceutical compositions of olanzapine and process for their preparation
CN102935074B (zh) * 2011-08-15 2015-04-22 成都康弘药业集团股份有限公司 一种盐酸曲唑酮渗透泵控释片
KR102241487B1 (ko) 2013-02-20 2021-04-16 주식회사 종근당 제어방출 펠릿으로 된 약제학적 조성물
KR101647978B1 (ko) * 2014-03-17 2016-08-24 한국과학기술원 마이크로캡슐을 이용한 삼투압의 직접 측정 방법
WO2016132220A1 (en) 2015-02-20 2016-08-25 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release oral dosage form of gaba receptor agonist

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US4016880A (en) * 1976-03-04 1977-04-12 Alza Corporation Osmotically driven active agent dispenser
US4271113A (en) * 1978-04-17 1981-06-02 Alza Corporation Process for forming a passageway in an osmotic device
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
DE20100700U1 (de) * 2001-01-16 2001-03-22 Eugster/Frismag Ag, Romanshorn Kaffeegetränkzubereitungsautomat, insbesondere Espressoautomat
DE60212475T2 (de) * 2001-03-14 2007-07-05 Pfizer Products Inc., Groton Pharmazeutische Tablette und ein Verfahren zu ihrer Herstellung
US20030143272A1 (en) * 2001-03-14 2003-07-31 Waterman Kenneth C. Pharmaceutical tablet and process for making thereof
US6809288B2 (en) * 2001-05-23 2004-10-26 Osmotica Corp. Laser drilling system and method

Also Published As

Publication number Publication date
EP1629835A2 (en) 2006-03-01
KR20120105058A (ko) 2012-09-24
WO2004103349A2 (es) 2004-12-02
KR20060015286A (ko) 2006-02-16
AR047204A1 (es) 2006-01-11
CA2526464C (en) 2010-06-29
WO2004103349A3 (es) 2005-03-31
CL2004001192A1 (es) 2005-03-28
CA2526464A1 (en) 2004-12-02
UY28326A1 (es) 2004-06-30

Similar Documents

Publication Publication Date Title
BRPI0410546A (pt) dispositivo de ruptura de liberação controlada com uma passagem pré-formada
BRPI0107761A (pt) dispositivo osmótico, bem como método para fabricação do mesmo.
BRPI0407373A (pt) Espuma hidro-alcoólica formando espuma em filme
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
BRPI0408396A (pt) pelìculas de dissolução rápida, consumìveis por via oral, contendo agentes farmaceuticamente ativos
UY28509A1 (es) Formas de dosificacion de azitromicina con efectos secundarios reducidos
BRPI0512878A (pt) formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
BRPI0413396A (pt) dispersão aquosa, método para produzir uma dispersão aquosa, camada de pelìcula e artigo
BRPI0509146B8 (pt) sistema de liberação de droga, método de fabricação do mesmo, e, uso do sistema de liberação de droga
CR10726A (es) Vacuna que comprende un adyuvante de emulsion de aceite en agua
DK1553927T3 (da) Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
BR0213948A (pt) Forma de dosagem de liberação controlada dual
BRPI0418252A (pt) dispositivo de proteção respiratória pessoal, e, método de fazer o mesmo
BRPI0411901A (pt) micropartìculas
CO5210862A1 (es) Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
CO5560568A2 (es) Composicion oftalmica que comprende ascomicina
MXPA05012319A (es) Suministro de compuestos con celulas sanguineas rehidratadas.
PE20030323A1 (es) Composicion farmaceutica
BRPI0506630A (pt) composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada
BRPI0611526A2 (pt) composição tópica contendo gelatina
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
BR9914644A (pt) Composições tamponadas para diálise
GT200200115AA (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion .
BRPI0504082A (pt) emulsões refrescantes medicinais
CO5560513A2 (es) Dispositivo de control de insectos que contiene coumaphos y diazinon para el tratamiento prolongado de animales

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 9/28; A61P 9/00, 21/00, 29/00, 25/22

Ipc: A61K 9/28 (2011.01), A61P 9/00 (2011.01), A61P 21/

B25A Requested transfer of rights approved

Owner name: OSMOTICA KERESKEDELMI ES SZOLGALGATO KFT (HU)

Free format text: TRANSFERIDO DE: OSMOTICA CORP.

B25G Requested change of headquarter approved

Owner name: OSMOTICA KERESKEDELMI ES SZOLGALGATO KFT (HU)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]